Insulin degludec and liraglutide

  • Biologic
  • Xultophy 100/3.6

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Insulin degludec and liraglutide: storage and handling

Refrigerate
Yes, as the label states
Label statement
Prior to first use, XULTOPHY 100/3.6 should be stored between 36°F to 46°F (2°C and 8°C) until the expiration date printed on the label.
Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
up to 21 days at or below 30°C (86°F)
Label statement
After first use, the XULTOPHY 100/3.6 pen can be stored for 21 days at controlled room temperature 59°F to 86°F (15°C to 30°C) or in a refrigerator 36°F to 46°F (2°C to 8°C).
Room temperature
up to 21 days at or below 30°C (86°F)
Label statement
Conditions for XULTOPHY 100/3.6 Pen Prior to first use After first use Refrigerated 36°F to 46°F (2°C to 8°C) Room Temperature 59°F to 86°F (15°C to 30°C) Refrigerated 36°F to 46°F (2°C to 8°C) Until expiration date 21 Days
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Store prefilled pens in the carton so they will stay clean and protected from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 21 days at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

After first use, the XULTOPHY 100/3.6 pen can be stored for 21 days at controlled room temperature 59°F to 86°F (15°C to 30°C) or in a refrigerator 36°F to 46°F (2°C to 8°C).

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-727-6500 (the number printed on the label) about this product.

Where the label prints this number
800 Scudders Mill Road Plainsboro, NJ 08536 1-800-727-6500 (Se habla español) www.novonordisk-us.com PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Xultophy ® 100/3.6 NDC 0169-2911-15 List: 291115 (insulin degludec and liraglutide) injection For Single Patient Use Only 100 units/mL and 3.6 mg/mL With each unit of insulin degludec, the pen also delivers 0.036 mg of liraglutide 5x3 mL Prefilled Pens For subcutaneous use only Recommended for use with NovoFine ® , Novofine ® Plus or NovoTwist ® disposable needles.
All storage statements on the label (9)
  • Prior to first use, XULTOPHY 100/3.6 should be stored between 36°F to 46°F (2°C and 8°C) until the expiration date printed on the label.
  • Store prefilled pens in the carton so they will stay clean and protected from light.
  • Do not store in the freezer or directly adjacent to the refrigerator cooling element.
  • Do not freeze.
  • Do not use XULTOPHY 100/3.6 if it has been frozen.
  • After first use, the XULTOPHY 100/3.6 pen can be stored for 21 days at controlled room temperature 59°F to 86°F (15°C to 30°C) or in a refrigerator 36°F to 46°F (2°C to 8°C).
  • Keep all XULTOPHY 100/3.6 pens away from direct heat and light.
  • Always remove the needle after each injection and store the XULTOPHY 100/3.6 pen without a needle attached.
  • Conditions for XULTOPHY 100/3.6 Pen Prior to first use After first use Refrigerated 36°F to 46°F (2°C to 8°C) Room Temperature 59°F to 86°F (15°C to 30°C) Refrigerated 36°F to 46°F (2°C to 8°C) Until expiration date 21 Days

FDA label version 14, effective October 14, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

34%of plans list it
0%of those: prior authorization
1%step therapy
98%quantity limit
0%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.